NSE · AI Signal & Stock Analysis · Neutral
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for CAPLIPOINT is Neutral → (extreme move); technical trend raise-2026-09-01; trading at ₹2,810.80 (-1.20% today); neutral (RSI 67).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Extreme move |
|---|---|
| Technical trend | RAISE-2026-09-01 |
| Price | ₹2,810.80 |
| Change today | -1.20% |
| RSI (14) | 67.00 |
| Relative volume | 1.07 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹21,694 Cr |
| P/E | 32.68 |
| Cap category | Large Cap |
| 52-week high | -1.2% away |
| 52-week low | +87.2% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for CAPLIPOINT (Caplin Point Laboratories Limited) is Neutral with a extreme move, and its technical trend is raise-2026-09-01. The composite score and full factor breakdown are available to signed-in members.
CAPLIPOINT's RSI is neutral (RSI 67). A reading above 70 is typically overbought and below 30 oversold.
CAPLIPOINT is trading about 1% below its 52-week high and 87% above its 52-week low as of Sep 28 2026, 6:47 PM.
CAPLIPOINT's market capitalisation is ₹21,694 Cr as of Sep 28 2026, 6:47 PM.
CAPLIPOINT is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for CAPLIPOINT — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.